Poor thyroid function can be treated through several drug choices.
Poor thyroid function can be treated through several drug choices. Hypo-thyroidism (hormone underproduction) is generally treated with levothyroxine (LT4). Hyperthyroidism (hormone overproduction) is generally treated with a thionamide medication such as methimazole or propylthiouracil (PTU).
Two hormones, T3 and T4, are produced by the thyroid gland.
"In a study of 50 euthyroid patients who underwent thyroidectomy and then received LT4 monotherapy for replacement, serum T3 concentrations after thyroidectomy were equivalent to those before surgery, indicating that LT4 monotherapy leads to adequate serum concentrations of T3," says Mark Abramowicz, MD, editor-in-chief of The Medical Letter on Drugs and Therapeutics, a non-profit newsletter that critically appraises drugs.
"When we first prescribe the medication, we check patients more frequently," says Peter A. Singer, MD, director of the Thyroid Diagnostic Center at the Keck School of Medicine at the University of Southern California, and a member of the board of the American Association of Clinical Endocrinologists. "Once patients are on an established dose of levothyroxine, monitoring is only necessary once a year unless something changes."
Alan P. Farwell, MD, director of the Endocrine Clinics at Boston Medical Center, says in his experience, when MCOs change the preferred brand of levothroxine on their formulary, they incur substantial increased costs because of additional office visits associated with members' medication changes.
Physicians don't experience similar problems with changes in brands of statin medications, for example, because a 15% change in potency of statins doesn't have a significant effect on the patient.
"I've been doing this for 25 years, and I've observed that each time the MCO changes to a different brand of levothroxine, the patient has to come in again for at least one extra visit," Dr. Farwell says.
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Ohio’s Medicaid Work Requirement Efforts Aim to Boost Engagement, Avoid Coverage Loss
April 18th 2025Maureen Corcoran, director of the Ohio Department of Medicaid, believes the work requirement policy can be both a financial and moral effort to improve the lives of Medicaid consumers.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Why Better Data and Awareness Matters for Medicaid Work Requirements
April 17th 2025With policymakers considering work requirements for Medicaid eligibility, Jennifer Haley, principal research associate in the Health Policy Division at the Urban Institute, said it’s more important than ever to understand how those changes could unintentionally cause harm, particularly when data systems fall short and public awareness is limited.
Read More